Tao Zuo | Profiles RNS

Tao Zuo, MD, PhD

Assistant Professor

Boston University Chobanian & Avedisian School of Medicine

Pathology & Laboratory Medicine

MD, Beijing Medical University
PhD, Ohio University

Websites

	Boston Medical Center Provider Profile
	ResearchGate
	LinkedIn

ORCID : 0000-0002-2125-7548

Publications
Contact Info

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Gao Z, Wang X, Zuo T, Zhang M, Zhang Z. A predictive nomogram for lymph node metastasis in part-solid invasive lung adenocarcinoma: A complement to the IASLC novel grading system. Front Oncol. 2022; 12:916889. PMID: 36046052; PMCID: PMC9423719; DOI: 10.3389/fonc.2022.916889;

Sun T, Zuo T, Hui P, Cai G. Significance of KRAS mutation testing in biliary brushing cytology specimens: A 10-year retrospective review. Cancer Cytopathol. 2022 Jul; 130(7):558-565. PMID: 35417072

Liao H, Sheridan T, Cosar E, Owens C, Zuo T, Wang X, Akalin A, Kandil D, Dresser K, Fogarty K, Bellve K, Baer C, Fischer A. Deconvolution microscopy: A platform for rapid on-site evaluation of fine needle aspiration specimens that enables recovery of the sample. Cytopathology. 2022 May; 33(3):312-320. PMID: 35102620; PMCID: PMC9305921; DOI: 10.1111/cyt.13106;

Zuo T, Wang L, Morrison C, Chang X, Zhang H, Li W, Liu Y, Wang Y, Liu X, Chan MWY, Liu JQ, Love R, Liu CG, Godfrey V, Shen R, Huang TH, Yang T, Park BK, Wang CY, Zheng P, Liu Y. FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important Repressor of the HER-2/ErbB2 Oncogene. Cell. 2021 Dec 22; 184(26):6378. PMID: 34942100

Zuo T, Levi AW, Lin Q, Abi-Raad R, Adeniran AJ, Cai G. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests. Am J Clin Pathol. 2021 Sep 08; 156(4):569-576. PMID: 33728437

Kritselis M, Yambayev I, Prilutskiy A, Shevtsov A, Vadlamudi C, Zheng H, Elsadwai M, Ma L, Aniskovich E, Kataria Y, Higgins S, Sarita-Reyes C, Zuo T, Zhao Q, Quillen K, Burks EJ. Distinctive pseudopalisaded histiocytic hyperplasia characterizes the transition of exudative to proliferative phase of diffuse alveolar damage in patients dying of COVID-19. Hum Pathol. 2021 10; 116:49-62.View Related Profiles.

Sarita-Reyes, Carmen
Vadlamudi, Charitha
Burks, Eric
Zheng, Hanqiao
Yambayev, Ilyas
Quillen, Karen
Zhao, Qing
Higgins, Sara
Zuo, Tao
Kataria, Yachana

PMID: 34273395; PMCID: PMC8278870; DOI: 10.1016/j.humpath.2021.06.008;

Wang L, Aschenbrenner D, Zeng Z, Cao X, Mayr D, Mehta M, Capitani M, Warner N, Pan J, Wang L, Li Q, Zuo T, Cohen-Kedar S, Lu J, Ardy RC, Mulder DJ, Dissanayake D, Peng K, Huang Z, Li X, Wang Y, Wang X, Li S, Bullers S, Gammage AN, Warnatz K, Schiefer AI, Krivan G, Goda V, Kahr WHA, Lemaire M, Lu CY, Siddiqui I, Surette MG, Kotlarz D, Engelhardt KR, Griffin HR, Rottapel R, Decaluwe H, Laxer RM, Proietti M, Hambleton S, Elcombe S, Guo CH, Grimbacher B, Dotan I, Ng SC, Freeman SA, Snapper SB, Klein C, Boztug K, Huang Y, Li D, Uhlig HH, Muise AM. Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice. Nat Genet. 2021 Apr; 53(4):500-510. PMID: 33782605; PMCID: PMC8245161; DOI: 10.1038/s41588-021-00803-4;

Sun T, Akalin A, Dresser K, Fischer AH, Zuo T. The Utility of MYB Immunohistochemistry (IHC) in Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (AdCC). Head Neck Pathol. 2021 Jun; 15(2):389-394. PMID: 32661670; PMCID: PMC8134651; DOI: 10.1007/s12105-020-01202-7;

Yoon EC, Wilson P, Zuo T, Pinto M, Cole K, Harigopal M. High frequency of p16 and SOX10 coexpression but not androgen receptor expression in triple-negative breast cancers. Hum Pathol. 2020 08; 102:13-22. PMID: 32565323

Zuo T, Wilson P, Cicek AF, Harigopal M. Androgen receptor expression is a favorable prognostic factor in triple-negative breast cancers. Hum Pathol. 2018 10; 80:239-245. PMID: 29902579

Showing 10 of 28 results. Show More

Zuo T, Wong S, Buza N, Hui P. KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome. Mod Pathol. 2018 Feb; 31(2):350-357. PMID: 29027536; DOI: 10.1038/modpathol.2017.121;

Liang Y, Zuo T. Papillary Thyroid Carcinoma Cervical Lymph Node Metastasis with Cystic Change Differentiated from Congenital Cystic Lesions with the Assistance of Immunohistochemistry: A Case Study. Head Neck Pathol. 2017 Sep; 11(3):301-305. PMID: 27770399; PMCID: PMC5550386; DOI: 10.1007/s12105-016-0762-1;

Fitzgerald E, Chen L, Guelrud M, Allison H, Zuo T, Suarez Y, Yoo J. Appendiceal Adenocarcinoma Presenting as a Rectal Polyp. Case Rep Gastroenterol. 2016; 10(1):24-9. PMID: 27403098; PMCID: PMC4929366; DOI: 10.1159/000442664;

Zhang M, Mahoney E, Zuo T, Manchanda PK, Davuluri RV, Kirschner LS. Protein kinase A activation enhances ß-catenin transcriptional activity through nuclear localization to PML bodies. PLoS One. 2014; 9(10):e109523. PMID: 25299576; PMCID: PMC4192022; DOI: 10.1371/journal.pone.0109523;

Rodriguez BA, Weng YI, Liu TM, Zuo T, Hsu PY, Lin CH, Cheng AL, Cui H, Yan PS, Huang TH. Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells. Carcinogenesis. 2011 Jun; 32(6):812-21. PMID: 21304052; PMCID: PMC3106431; DOI: 10.1093/carcin/bgr017;

Xu RX, Xu JS, Zuo T, Shen R, Huang TH, Tweedle MF. Drug-loaded biodegradable microspheres for image-guided combinatory epigenetic therapy in cells. J Biomed Opt. 2011 Feb; 16(2):020507. PMID: 21361663; PMCID: PMC3188613; DOI: 10.1117/1.3548878;

Zuo T, Liu TM, Lan X, Weng YI, Shen R, Gu F, Huang YW, Liyanarachchi S, Deatherage DE, Hsu PY, Taslim C, Ramaswamy B, Shapiro CL, Lin HJ, Cheng AS, Jin VX, Huang TH. Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer. Cancer Res. 2011 Mar 01; 71(5):1752-62. PMID: 21216892; PMCID: PMC3048165; DOI: 10.1158/0008-5472.CAN-10-3573;

Weng YI, Hsu PY, Liyanarachchi S, Liu J, Deatherage DE, Huang YW, Zuo T, Rodriguez B, Lin CH, Cheng AL, Huang TH. Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. Toxicol Appl Pharmacol. 2010 Oct 15; 248(2):111-21. PMID: 20678512; PMCID: PMC2946518; DOI: 10.1016/j.taap.2010.07.014;

Zuo T, Tycko B, Liu TM, Lin JJ, Huang TH. Methods in DNA methylation profiling. Epigenomics. 2009 Dec; 1(2):331-45. PMID: 20526417; PMCID: PMC2880494; DOI: 10.2217/epi.09.31;

Wang L, Liu R, Li W, Chen C, Katoh H, Chen GY, McNally B, Lin L, Zhou P, Zuo T, Cooney KA, Liu Y, Zheng P. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell. 2009 Oct 06; 16(4):336-46. PMID: 19800578; PMCID: PMC2758294; DOI: 10.1016/j.ccr.2009.08.016;

Hsu PY, Deatherage DE, Rodriguez BA, Liyanarachchi S, Weng YI, Zuo T, Liu J, Cheng AS, Huang TH. Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res. 2009 Jul 15; 69(14):5936-45. PMID: 19549897; PMCID: PMC2855843; DOI: 10.1158/0008-5472.CAN-08-4914;

Lin HJ, Zuo T, Chao JR, Peng Z, Asamoto LK, Yamashita SS, Huang TH. Seed in soil, with an epigenetic view. Biochim Biophys Acta. 2009 Sep; 1790(9):920-4. PMID: 19162126; PMCID: PMC2845923; DOI: 10.1016/j.bbagen.2008.12.004;

Lin HJ, Zuo T, Lin CH, Kuo CT, Liyanarachchi S, Sun S, Shen R, Deatherage DE, Potter D, Asamoto L, Lin S, Yan PS, Cheng AL, Ostrowski MC, Huang TH. Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells. Cancer Res. 2008 Dec 15; 68(24):10257-66. PMID: 19074894; PMCID: PMC2821873; DOI: 10.1158/0008-5472.CAN-08-0288;

Zuo T, Liu R, Zhang H, Chang X, Liu Y, Wang L, Zheng P, Liu Y. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Invest. 2007 Dec; 117(12):3765-73. PMID: 18008005; PMCID: PMC2075479; DOI: 10.1172/JCI32538;

Zuo T, Wang L, Morrison C, Chang X, Zhang H, Li W, Liu Y, Wang Y, Liu X, Chan MW, Liu JQ, Love R, Liu CG, Godfrey V, Shen R, Huang TH, Yang T, Park BK, Wang CY, Zheng P, Liu Y. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell. 2007 Jun 29; 129(7):1275-86. PMID: 17570480; PMCID: PMC1974845; DOI: 10.1016/j.cell.2007.04.034;

Chang X, Gao JX, Jiang Q, Wen J, Seifers N, Su L, Godfrey VL, Zuo T, Zheng P, Liu Y. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J Exp Med. 2005 Oct 17; 202(8):1141-51. PMID: 16230479; PMCID: PMC2213221; DOI: 10.1084/jem.20050157;

Liu X, Gao JX, Wen J, Yin L, Li O, Zuo T, Gajewski TF, Fu YX, Zheng P, Liu Y. B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med. 2003 Jun 16; 197(12):1721-30. PMID: 12810690; PMCID: PMC2193953; DOI: 10.1084/jem.20022089;

Wang L, Habuchi T, Takahashi T, Kamoto T, Zuo T, Mitsumori K, Tsuchiya N, Sato K, Ogawa O, Kato T. No association between HER-2 gene polymorphism at codon 655 and a risk of bladder cancer. Int J Cancer. 2002 Feb 20; 97(6):787-90. PMID: 11857355; DOI: 10.1002/ijc.10129;

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 28 publications over 15 distinct years, with a maximum of 4 publications in 2021

Bar chart showing 28 publications over 15 distinct years, with a maximum of 4 publications in 2021

Year	Publications
2002	1
2003	1
2005	1
2007	2
2008	2
2009	3
2010	1
2011	3
2014	1
2016	2
2017	1
2018	1
2020	2
2021	4
2022	3

Contact for Mentoring:

670 Albany Street
Boston MA 02118
Google Map

617.414.3701

Download vCard

Zuo's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (221) concept(s)

Co-Authors

See all (7) people

Similar People

See all (60) people

Same Department

Search Department